GAS7 Human

Growth Arrest-Specific 7 Isoform b Human Recombinant
Shipped with Ice Packs
In Stock

Description

Neuronal Development

  • Neurite Outgrowth: GAS7 promotes morphological differentiation of cerebellar neurons. Knockdown experiments in murine models impair neurite extension, while overexpression enhances it .

  • Cytoskeletal Regulation: Interacts with actin and microtubules to stabilize cytoskeletal structures. Mice lacking functional GAS7 exhibit motor deficits and abnormal neuromuscular junctions .

Phagocytosis

  • GAS7 localizes to phagocytic cups in macrophages, facilitating engulfment of pathogens like zymosan. Its F-BAR domain directly mediates membrane deformation, with mutations (e.g., D207R, K209E) abolishing this function .

Cancer Biology

  • Breast Cancer: Reduced GAS7b expression correlates with early-onset breast cancer (≤40 years), lymph node metastasis, and poor survival. GAS7 suppresses metastasis by inhibiting Rac1-mediated actin polymerization and β1-integrin/FAK/Src signaling .

  • Regulation by p53: Wild-type p53 upregulates GAS7, while p53 mutations (common in early-onset cases) reduce its expression, enabling tumor progression .

Neurological Disorders

  • Gas7-deficient mice show motor dysfunction and muscle fiber abnormalities, mimicking aspects of amyotrophic lateral sclerosis (ALS) .

  • Altered GAS7 expression is implicated in schizophrenia due to disrupted neurite connectivity during brain development .

Therapeutic Potential

AreaMechanismReference
NeurodegenerationEnhancing GAS7 expression to restore neurite outgrowth
Cancer ImmunotherapyTargeting GAS7-p53 axis to inhibit metastasis
Infection ControlModulating GAS7-mediated phagocytosis in macrophages

Isoform-Specific Roles

IsoformDomainsFunction
GAS7bF-BAR, WWDominant in macrophages; rescues phagocytosis
GAS7cF-BAR, WW, SH3Less studied; minor role in neuronal cells
GAS7dF-BAR onlyUnknown; potentially redundant

Expression and Detection

  • Detection Methods: Western blotting, immunohistochemistry (high expression in brain tissues) .

  • Cellular Models: RAW264.7 macrophages and HeLa cells are used to study phagocytic and neurite-outgrowth roles, respectively .

Product Specs

Introduction
GAS7, primarily found in mature brain cells, especially cerebellar Purkinje neurons, plays a crucial role in neuronal development. It promotes the maturation and morphological differentiation of cerebellar neurons. Inhibiting GAS7 production in developing embryonic murine cerebellum cultures hinders neurite outgrowth. Conversely, overexpressing GAS7 can trigger the development of human osteosarcoma.
Description
This product consists of the GAS7 protein, produced in E. coli. It is a single, non-glycosylated polypeptide chain comprising 436 amino acids (1-416 a.a.) with a molecular weight of 49.8 kDa. A 20 amino acid His Tag is fused to the N-terminus of the protein. Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
A sterile, colorless solution, free of any particles.
Formulation
The GAS7 protein is supplied in a solution containing 20mM Tris-HCl (pH 8), 100mM NaCl, 2mM DTT, and 10% glycerol.
Stability
For short-term storage (up to 4 weeks), keep the vial refrigerated at 4°C. For long-term storage, freeze the solution at -20°C. Adding a carrier protein like 0.1% HSA or BSA is recommended for extended storage. Avoid repeatedly freezing and thawing the product.
Purity
The purity of the GAS7 protein is greater than 95%, as determined by SDS-PAGE analysis.
Synonyms
GAS7, GAS-7, Growth arrest-specific protein 7, KIAA0394, MGC1348, MLL/GAS7.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MKPGMVPPPP GEESQTVILP PGWQSYLSPQ GRRYYVNTTT NETTWERPSS SPGIPASPGS HRSSLPPTVN GYHASGTPAH PPETAHMSVR KSTGDSQNLG SSSPSKKQSK ENTITINCVT FPHPDTMPEQ QLLKPTEWSY CDYFWADKKD PQGNGTVAGF ELLLQKQLKG KQMQKEMSEF IRERIKIEED YAKNLAKLSQ NSLASQEEGS LGEAWAQVKK SLADEAEVHL KFSAKLHSEV EKPLMNFREN FKKDMKKCDH HIADLRKQLA SRYASVEKAR KALTERQRDL EMKTQQLEIK LSNKTEEDIK KARRKSTQAG DDLMRCVDLY NQAQSKWFEE MVTTTLELER LEVERVEMIR QHLCQYTQLR HETDMFNQST VEPVDQLLRK VDPAKDRELW VREHKTGNIR PVDMEI.

Q&A

What is GAS7 and what is its fundamental role in cellular processes?

GAS7 (Growth Arrest-Specific 7) is a member of the growth arrest-specific gene family that is preferentially expressed when cells enter a quiescent state. The gene encodes a 48-kDa protein that contains structural domains resembling OCT2 (a POU transcription factor involved in neuronal development) and synapsins (proteins that modulate neurotransmitter release) . Based on experimental evidence, GAS7 plays a critical role in neuronal development, particularly in promoting neurite outgrowth in cerebellar neurons and neuroblastoma cells . The protein appears to be involved in morphological differentiation of neurons rather than biochemical differentiation, suggesting a specific role in structural neuronal development.

Where is GAS7 primarily expressed in human tissues and at what developmental stages?

GAS7 expression demonstrates strong tissue specificity. Northern blot analyses reveal that GAS7 is abundantly expressed in the brain, particularly in the cerebellum, with moderate expression in the hippocampus, and lower levels in the cerebral cortex and caudate putamen . Outside the central nervous system, GAS7 is expressed at significantly lower levels in the heart and testes . Within the cerebellum, GAS7 is prominently expressed in the Purkinje neuron layer, with additional expression in granule and molecular layers as demonstrated through in situ hybridization and immunohistochemical analyses . Developmentally, GAS7 expression is associated with mature, growth-arrested neurons, suggesting its upregulation correlates with terminal differentiation rather than proliferative stages of neuronal development.

What is the chromosomal location of the human GAS7 gene and how is it structurally organized?

The human GAS7 gene maps to chromosome 17, specifically on the short arm, which is largely syntenic with mouse chromosome 11 where the murine GAS7 gene is located . The human genomic DNA sequence shows approximately 85% identity to the mouse GAS7 cDNA . The gene produces multiple transcript variants through alternative splicing, with Northern blot analysis detecting two major species of GAS7 transcripts in brain tissue: one approximately 3 kb and another approximately 8 kb in length . The larger transcript (similar to human cDNA clone AB007854/KIAA0394 at 7,979 nucleotides) differs primarily in having a much longer 3' untranslated region, suggesting differential splicing at sites in this region .

What are the key structural domains of the GAS7 protein and how do they relate to its function?

The GAS7 protein contains several important structural domains that contribute to its functionality:

  • A proline-rich N-terminal region (amino acids 3-30) that shows 43% identity to the C-terminus of OCT2, a POU transcription factor involved in neuronal development .

  • The same N-terminal segment (amino acids 2-29) exhibits 48% identity with a region (amino acids 23-47) of synapsins Ia and Ib, which are involved in modulating neurotransmitter release .

  • A WW (Trp-Trp) module between amino acids 22-60 that mediates protein-protein interactions through linking proline-rich regions .

  • A segment resembling (seven of eight amino acids are identical) a region present in CDC9, a yeast ATP synthetase known to be cell-cycle regulated .

These structural features suggest that GAS7 may function by interacting with other proteins through its WW domain and proline-rich regions, potentially influencing cytoskeletal organization and gene expression in neurons.

How does the amino acid sequence of human GAS7 compare to its orthologs in other species?

The human GAS7 protein demonstrates high conservation with its murine ortholog. A human cDNA clone (AB007854/KIAA0394) encodes a predicted open reading frame of 412 amino acids, of which 401 (97%) are identical to the amino acid sequences of mouse GAS7 . This extraordinary level of conservation suggests strong evolutionary pressure to maintain GAS7's structure and function across mammalian species, further supporting its biological significance. The human genomic DNA sequence shows approximately 85% nucleotide identity to mouse GAS7 cDNA , indicating high conservation at both the nucleotide and protein levels.

What protein isoforms of GAS7 exist and how do they differ functionally?

Western blot analysis of mouse cerebellar extracts revealed multiple GAS7 protein species: a dominant 48-kDa protein and additional bands at 55 kDa and 63 kDa . The 48-kDa protein's N-terminal amino acid sequence (PPPPG) matched the sequence predicted from the cloned GAS7 cDNA . The other immunoreactive bands likely represent products of alternatively spliced GAS7 transcripts, such as those identified in growth-arrested NIH 3T3 fibroblasts . The functional differences between these isoforms remain to be fully characterized, but their differential expression patterns suggest they may have distinct roles in various cellular contexts or developmental stages.

What techniques are most effective for detecting GAS7 expression in tissue samples?

Based on published research, several complementary techniques have proven effective for detecting GAS7 expression:

  • Northern Blot Analysis: Effective for quantifying GAS7 transcript levels across different tissues and identifying transcript variants (3 kb and 8 kb species) .

  • In Situ Hybridization: Provides spatial resolution of GAS7 mRNA expression within tissue sections, particularly useful for brain regions. The technique revealed prominent expression in the cerebellum, moderate expression in the hippocampus, and lower levels in the cerebral cortex and caudate putamen .

  • Immunohistochemistry: Using antibodies raised against histidine-tagged, full-length GAS7 protein, this technique allows visualization of GAS7 protein localization within cells and tissues. It confirmed high expression in the cerebellum and hippocampus and revealed subcellular localization in both cell bodies and neurites of expressing neurons .

  • Western Blot Analysis: Enables detection and quantification of GAS7 protein isoforms (48 kDa, 55 kDa, and 63 kDa bands) in tissue extracts and cell cultures .

  • Immunofluorescence with Confocal Microscopy: Particularly useful for co-localization studies with cell-specific markers such as MAPII (neuronal marker), calbindin (Purkinje cell marker), and GFAP (glial marker) .

What are the most reliable methods for manipulating GAS7 expression in experimental models?

Several approaches have been successfully employed to manipulate GAS7 expression:

  • Antisense Oligonucleotides: Treatment of cultured cerebellar neurons with antisense oligonucleotides complementary to the 5'-end of GAS7 transcripts effectively decreased the abundance of all three GAS7 protein bands detected by Western blot . This approach is suitable for transient knockdown of GAS7 expression in primary cultures.

  • Overexpression Systems: Transfection of neuroblastoma cell lines (e.g., Neuro 2A) with GAS7 expression vectors effectively induced overexpression, resulting in dramatic morphological changes including abundant neurite-like extensions .

  • Cell Culture Models: Primary cultures of embryonic cerebellar neurons provide a physiologically relevant system for studying GAS7 function, particularly in Purkinje cells .

For more comprehensive manipulation, researchers might consider additional techniques not mentioned in the provided literature, such as CRISPR/Cas9 gene editing for stable knockout or knockin models, or inducible expression systems for temporal control of GAS7 expression.

How can researchers effectively distinguish between different GAS7 isoforms in experimental settings?

To effectively distinguish between GAS7 isoforms, researchers should consider a multi-faceted approach:

  • Western Blot Analysis with High-Resolution Gels: This technique can separate the different isoforms based on their molecular weights (48 kDa, 55 kDa, and 63 kDa) .

  • Isoform-Specific Antibodies: Development of antibodies that target unique regions of specific isoforms would allow for selective detection.

  • PCR with Isoform-Specific Primers: Designing primers that span unique exon junctions can enable selective amplification and quantification of specific transcript variants.

  • Mass Spectrometry: For protein-level analysis, mass spectrometry can provide definitive identification of isoform-specific peptides.

  • Sequential Immunoprecipitation: This approach can be used to purify specific isoforms for further characterization, as was done for the 48-kDa GAS7 protein to confirm its N-terminal sequence .

What is the precise role of GAS7 in neurite outgrowth and neuronal differentiation?

GAS7 appears to play a critical role in promoting neurite outgrowth during neuronal differentiation, particularly in cerebellar Purkinje cells. Experimental evidence supporting this role includes:

  • Loss-of-Function Studies: Treatment of cultured cerebellar neurons with GAS7 antisense oligonucleotides led to decreased GAS7 expression and a corresponding reduction in neurite formation in GAS7-expressing cells, including Purkinje cells .

  • Gain-of-Function Studies: Overexpression of GAS7 in Neuro 2A neuroblastoma cells induced dramatic morphological changes, promoting abundant lengthy neurite-like extensions in 65% of cells compared to less than 17% in control cells .

Importantly, while GAS7 appears to strongly influence morphological differentiation (neurite outgrowth), it does not necessarily induce biochemical differentiation markers. For example, the neurite-like extensions induced by GAS7 overexpression in Neuro 2A cells were not accompanied by detectable MAPII production, which is typically observed during retinoic acid-induced differentiation . This suggests that GAS7 may specifically regulate cytoskeletal reorganization required for neurite extension rather than the full differentiation program.

How does GAS7 interact with the cytoskeleton and related signaling pathways during neurite formation?

While the exact mechanisms remain to be fully elucidated, several structural features of GAS7 suggest potential interactions with the cytoskeleton and related signaling pathways:

  • Similarity to Synapsins: The N-terminal region of GAS7 shows significant homology to synapsins, which are known to tether synaptic vesicles to the cytoskeleton . Overexpression of synapsins in fibroblasts or neuroblastoma cells results in neurite outgrowth similar to the effects of GAS7 overexpression .

  • WW Domain: GAS7 contains a WW module (amino acids 22-60) that mediates protein-protein interactions through linking proline-rich regions . This domain may facilitate interactions with cytoskeletal components or regulatory proteins.

  • Localization Pattern: GAS7 is detected prominently in the cytoplasm of both cell bodies and neurites of expressing cells , consistent with a role in cytoskeletal organization.

These features suggest that GAS7 may promote neurite outgrowth by influencing cytoskeletal dynamics, potentially through direct interactions with cytoskeletal components or by modulating signaling pathways that regulate cytoskeletal reorganization.

What are the implications of GAS7's selective expression in Purkinje cells for cerebellar function?

The prominent expression of GAS7 in cerebellar Purkinje cells has several potential implications for cerebellar function:

  • Specialized Morphology: Purkinje cells have a highly elaborate dendritic arborization that receives extensive synaptic inputs, and GAS7's role in promoting neurite outgrowth may be particularly important for establishing and maintaining this complex morphology .

  • Integration Node: Purkinje cells serve as the sole output neurons of the cerebellar cortex, integrating signals from parallel and climbing fibers. GAS7's expression in these cells suggests it may contribute to their integrative functions.

  • Developmental Regulation: The inhibition of GAS7 expression in cerebellar cultures impedes neurite formation in Purkinje cells , suggesting that GAS7 is required for the proper morphological development of these neurons and, by extension, normal cerebellar circuit formation.

  • Maintenance of Neuronal Architecture: Given that GAS7 is expressed in mature, growth-arrested neurons , it may play a role in maintaining the intricate architecture of Purkinje cells throughout adulthood.

The selective expression of GAS7 in Purkinje cells, along with its demonstrated role in neurite outgrowth, suggests that it contributes to the distinctive morphological and functional properties of these neurons that are essential for cerebellar information processing.

What is known about GAS7 mutations or expression changes in neurological disorders?

  • Cerebellar Ataxias: Given GAS7's importance in Purkinje cell development and maintenance, mutations or expression changes could potentially contribute to cerebellar ataxias characterized by Purkinje cell dysfunction or degeneration.

  • Neurodevelopmental Disorders: As GAS7 influences neurite outgrowth , alterations in its function could theoretically impact neuronal connectivity during development, potentially contributing to neurodevelopmental disorders.

Further research is needed to establish direct links between GAS7 and specific neurological conditions. Researchers may consider screening for GAS7 mutations in patients with cerebellar disorders or investigating GAS7 expression in post-mortem brain tissue from individuals with relevant neurological conditions.

How might understanding GAS7 function contribute to developing therapies for neurodegenerative diseases?

Understanding GAS7 function could potentially contribute to therapeutic strategies for neurodegenerative diseases in several ways:

  • Promoting Neuronal Regeneration: Given GAS7's ability to induce neurite outgrowth when overexpressed in neuroblastoma cells , it could potentially be targeted to promote regeneration of damaged neurons in neurodegenerative conditions.

  • Maintaining Neuronal Architecture: As GAS7 is expressed in mature neurons and appears important for maintaining neuronal morphology , preserving or enhancing its function might help prevent the structural degeneration characteristic of many neurodegenerative diseases.

  • Biomarker Development: Changes in GAS7 expression or function could potentially serve as biomarkers for specific neurodegenerative processes, particularly those affecting cerebellar Purkinje cells.

  • Targeted Drug Development: The specific structural domains of GAS7, such as the WW module that mediates protein-protein interactions , could potentially be targeted by drugs designed to modulate its function in disease states.

While these potential therapeutic applications are speculative based on the limited information in the search results, they represent logical extensions of the known functions of GAS7 in neuronal development and maintenance.

What experimental models would be most appropriate for studying GAS7 in the context of human neurological conditions?

Based on the information provided and the known functions of GAS7, several experimental models would be appropriate for studying its role in human neurological conditions:

  • Primary Cerebellar Neuron Cultures: These have already been successfully used to study GAS7 function in neurite outgrowth and would be particularly relevant for cerebellar disorders.

  • hiPSC-Derived Neurons: Human induced pluripotent stem cells (hiPSCs) derived from patients with neurological disorders could be differentiated into neurons to study GAS7 expression and function in a disease-relevant context.

  • Organoids: Cerebral or cerebellar organoids could provide a three-dimensional model to study GAS7's role in neuronal development and circuit formation in a more complex environment.

  • Conditional Knockout Mouse Models: Tissue-specific and/or inducible knockout of GAS7 in mice would allow for investigation of its role in specific neuronal populations and at different developmental stages.

  • Transgenic Models Expressing Human GAS7 Variants: These could be used to study the effects of specific GAS7 mutations identified in human neurological disorders.

Each of these models offers distinct advantages and limitations, and a comprehensive understanding of GAS7's role in human neurological conditions would likely require integration of findings across multiple experimental systems.

How does alternative splicing regulate GAS7 function in different cellular contexts?

The search results indicate that GAS7 undergoes alternative splicing, leading to multiple transcript variants and protein isoforms . Understanding how this splicing is regulated and how the resulting isoforms function differently represents an important research direction:

  • Splice Variant Characterization: Comprehensive characterization of all GAS7 splice variants in different tissues and developmental stages would provide insights into their specific roles.

  • Isoform-Specific Functions: Determining whether different GAS7 isoforms (48 kDa, 55 kDa, and 63 kDa) have distinct functions in neurite outgrowth or other processes would be valuable .

  • Splicing Regulation: Investigating the factors that regulate alternative splicing of GAS7 in different cellular contexts could reveal how its expression is fine-tuned for specific functions.

  • Developmental Dynamics: Examining how the relative abundance of different GAS7 isoforms changes during neuronal development could provide insights into their stage-specific roles.

Methodologically, this would require a combination of RNA-seq to identify all splice variants, isoform-specific knockdown or overexpression to determine their individual functions, and analysis of splicing factors that interact with the GAS7 pre-mRNA.

What is the relationship between GAS7's growth arrest-specific expression in fibroblasts and its role in post-mitotic neurons?

GAS7 was originally identified as a gene expressed preferentially in growth-arrested fibroblasts , but its prominent expression in mature, post-mitotic neurons suggests a broader role in terminally differentiated cells:

  • Common Mechanisms: Investigating whether similar molecular pathways regulate GAS7 expression in growth-arrested fibroblasts and post-mitotic neurons could reveal common mechanisms of growth arrest and terminal differentiation.

  • Functional Conservation: Determining whether GAS7 performs similar functions in both cell types, such as regulating cytoskeletal organization or maintaining cellular architecture, would be informative.

  • Cell Cycle Exit: Exploring GAS7's potential role in promoting or maintaining cell cycle exit in both fibroblasts and neurons could provide insights into its fundamental function.

  • Evolutionary Perspective: Examining whether GAS7's dual role in growth arrest and neuronal differentiation is conserved across species could shed light on its evolutionary significance.

Research approaches might include comparative transcriptomic and proteomic analyses of growth-arrested fibroblasts and mature neurons, as well as functional studies of GAS7 in both cellular contexts.

How does GAS7 interact with the transcriptional machinery given its homology to transcription factors?

The N-terminal region of GAS7 shows significant homology to the proline-rich transcription activation domain of OCT2, a POU transcription factor involved in neuronal development . This raises important questions about potential interactions with the transcriptional machinery:

  • Nuclear Localization: While GAS7 has been detected primarily in the cytoplasm , investigating whether a portion localizes to the nucleus under specific conditions would be important.

  • Transcriptional Effects: Determining whether GAS7 overexpression or knockdown affects the transcription of specific genes would help establish whether it has direct or indirect transcriptional functions.

  • Protein Interactions: Identifying proteins that interact with the OCT2-homologous region of GAS7 could reveal connections to transcriptional complexes.

  • Dual Functionality: Exploring whether GAS7 has dual functions in both cytoskeletal organization (through its synapsin-homologous region) and transcriptional regulation (through its OCT2-homologous region) would be a fascinating research direction.

Methodological approaches might include ChIP-seq to identify potential DNA-binding sites, RNA-seq following GAS7 manipulation to identify transcriptional effects, and protein interaction studies focused specifically on the OCT2-homologous region.

Product Science Overview

Structure and Production

The GAS7 Isoform b is produced in Escherichia coli (E. coli) as a single, non-glycosylated polypeptide chain containing 436 amino acids. It has a molecular mass of approximately 49.8 kDa. The recombinant protein is fused to a 20 amino acid His Tag at the N-terminus, which facilitates its purification through chromatographic techniques .

Function and Biological Activity

GAS7 is primarily expressed in the brain and is believed to play a crucial role in the development and maintenance of the nervous system. It is involved in the regulation of neuronal differentiation and neurite outgrowth. The protein has been implicated in various cellular processes, including:

  • Cell Growth Arrest: GAS7 is associated with the arrest of cell growth, which is essential for the proper differentiation of cells.
  • Neuronal Differentiation: It promotes the differentiation of neuronal cells, contributing to the development of the nervous system.
  • Cytoskeletal Organization: GAS7 interacts with the cytoskeleton, influencing cell shape and motility.
Applications

The recombinant form of GAS7 Isoform b is used in various research applications, including:

  • Neuroscience Research: To study the role of GAS7 in neuronal differentiation and development.
  • Cell Biology: To investigate the mechanisms of cell growth arrest and differentiation.
  • Drug Development: As a potential target for therapeutic interventions in neurodegenerative diseases and other conditions involving abnormal cell growth.
Storage and Stability

The recombinant GAS7 Isoform b protein is typically stored at 4°C if it is to be used within 2-4 weeks. For longer-term storage, it is recommended to store the protein at -20°C with the addition of a carrier protein such as 0.1% Human Serum Albumin (HSA) or Bovine Serum Albumin (BSA) to prevent degradation. It is important to avoid multiple freeze-thaw cycles to maintain the protein’s stability and activity .

Formulation and Purity

The GAS7 protein solution is formulated with 20mM Tris-HCl (pH 8), 100mM NaCl, 2mM DTT, and 10% glycerol. The purity of the protein is greater than 95.0% as determined by SDS-PAGE .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.